Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists
The cyclic production of estrogen and progesterone by the premenopausal ovary accounts for the steep rise in breast cancer risk in premenopausal women. These hormones are breast cell mitogens. By reducing exposure to these ovarian hormones, agonists of luteinizing hormone-releasing hormone (LHRH) gi...
保存先:
| 出版年: | Breast Cancer Res |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2000
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138786/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11250719/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr67 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|